CONSOLIDATED STATEMENTS OF CHANGES IN CONTINGENTLY REDEEMABLE NONCONTROLLING INTEREST AND EQUITY - USD ($) $ in Millions	Total	Sempra shareholders' equity	Preferred stock	Common stock	Retained earnings	AOCI	NCI	Preferred Class C	Preferred Class C Sempra shareholders' equity	Preferred Class C Retained earnings
Beginning Balance at Dec. 31, 2022	$ 29,256	$ 27,115	$ 889	$ 12,160	$ 14,201	$ (135)	$ 2,141
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,618	3,075			3,075		543
Other comprehensive income (loss)	3	31				31	(28)
Share-based compensation expense	80	80		80
Dividends declared:
Preferred dividends								$ (44)	$ (44)	$ (44)
Common stock dividends	(1,499)	(1,499)			(1,499)
Preferred dividends of subsidiary	(1)	(1)			(1)
Issuances of common stock	144	144		144
Repurchases of common stock	(32)	(32)		(32)
CRNCI and NCI activities:
Contributions	1,625	(145)		(145)			1,770
Distributions to NCI	(730)						(730)
Sales	1,234	(49)		(3)		(46)	1,283
Ending balance at Dec. 31, 2023	33,654	28,675	889	12,204	15,732	(150)	4,979
Ending balance at Dec. 31, 2024	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,500	2,862			2,862		638
Other comprehensive income (loss)	(5)	(16)				(16)	11
Share-based compensation expense	86	86		86
Dividends declared:
Preferred dividends								(44)	(44)	(44)
Common stock dividends	(1,570)	(1,570)			(1,570)
Preferred dividends of subsidiary	(1)	(1)			(1)
Issuances of common stock	1,273	1,273		1,273
Repurchases of common stock	(43)	(43)		(43)
CRNCI and NCI activities:
Contributions	1,235						1,235
Distributions to NCI	(297)						(297)
Ending balance at Dec. 31, 2024	37,788	31,222	889	13,520	16,979	(166)	6,566
CRNCI
CRNCI net loss	(3)
Contributions from CRNCI	5,248
Investor equity subscription	76
Allocation of interests	(2,115)
Ending balance at Dec. 31, 2025	3,206
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,072
Net income (loss)	2,075	1,837			1,837		238
Other comprehensive income (loss)	(36)	(31)				(31)	(5)
Share-based compensation expense	64	64		64
Dividends declared:
Preferred dividends								(29)	$ (29)	$ (29)
Common stock dividends	(1,683)	(1,683)			(1,683)
Redemption of preferred stock	(900)	(900)	(900)					$ (900)
Preferred deemed dividends	0	0	11		(11)
Preferred dividends of subsidiary	(1)	(1)			(1)
Issuances of common stock	84	84		84
Repurchases of common stock	(58)	(58)		(58)
CRNCI and NCI activities:
Investor equity subscription	25	16		16			9
Allocation of interests	1,746	1,073		1,073			673
Contributions	327						327
Distributions to NCI	(609)						(609)
Ending balance at Dec. 31, 2025	$ 38,793	$ 31,594	$ 0	$ 14,699	$ 17,092	$ (197)	$ 7,199